Ultragenyx Pharmaceutical
RARE
HK$252.12
Share price
-7.69%
Change (1 day)
-35.91%
Change (1 year)
Categories
Revenue for Ultragenyx Pharmaceutical (RARE)
Revenue in 2024 (TTM): HK$4.36 Billion
According to Ultragenyx Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is HK$4.35 Billion. an increase over the revenue in the year 2023 that were of HK$3.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ultragenyx Pharmaceutical from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$4.34 B | 28.24% |
| 2023 | HK$3.39 B | 19.47% |
| 2022 | HK$2.83 B | 3.6% |
| 2021 | HK$2.74 B | 30.41% |
| 2020 | HK$2.10 B | 160.12% |
| 2019 | HK$0.80 B | 100.31% |
| 2018 | HK$0.40 B | 1876.01% |
| 2017 | HK$20.4 M | 1878.7% |
| 2016 | HK$1.03 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | HK$22.18 B | 409.42% | 🇺🇸 USA |
 | HK$4.10 B | -5.70% | 🇺🇸 USA |
 | HK$2.58 B | -40.68% | 🇺🇸 USA |
 | HK$0.24 B | -94.45% | 🇺🇸 USA |